Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Epigenetic changes triggered by cigarette smoke may be earliest step in lung cancer development

Epigenetic changes triggered by cigarette smoke may be earliest step in lung cancer development

PXi multi-application imager used for new fluorescent peptide imaging application

PXi multi-application imager used for new fluorescent peptide imaging application

Researcher develops bone marrow models to study hematological and musculoskeletal diseases

Researcher develops bone marrow models to study hematological and musculoskeletal diseases

Researchers investigate link between thyroid hormone and red blood cell production

Researchers investigate link between thyroid hormone and red blood cell production

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

FDA approves drug to treat patients with newly diagnosed CD33-positive AML

Pfizer receives FDA approval for new therapy to treat adults and children with AML

Pfizer receives FDA approval for new therapy to treat adults and children with AML

Researchers reveal therapeutic benefits of melatonin for treating blood cancers

Researchers reveal therapeutic benefits of melatonin for treating blood cancers

Spot Leukaemia campaign launched to reduce delays in diagnosis

Spot Leukaemia campaign launched to reduce delays in diagnosis

UChicago Medicine working with Novartis to offer breakthrough gene therapy for pediatric ALL patients

UChicago Medicine working with Novartis to offer breakthrough gene therapy for pediatric ALL patients

FDA makes the first gene therapy Kymriah available for treatment of pediatric ALL

FDA makes the first gene therapy Kymriah available for treatment of pediatric ALL

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Novartis gets FDA approval for novel immunocellular therapy to treat relapsed or refractory B-cell ALL

Pioneering cancer gene therapy gets green light — and $475,000 price tag

Pioneering cancer gene therapy gets green light — and $475,000 price tag

FDA approves first cell-based gene therapy for use in the United States

FDA approves first cell-based gene therapy for use in the United States

Researchers develop new approach to efficiently produce versatile antibody therapies

Researchers develop new approach to efficiently produce versatile antibody therapies

Extensive analysis reveals immune system dynamics after stem cell transplantation in leukemia patients

Extensive analysis reveals immune system dynamics after stem cell transplantation in leukemia patients

Study finds low HPV vaccination rates among childhood cancer survivors

Study finds low HPV vaccination rates among childhood cancer survivors

UC San Diego researchers receive $18.2 million grant for B cell cancer clinical trial

UC San Diego researchers receive $18.2 million grant for B cell cancer clinical trial

New research program receives DKK 100 million in funding from Novo Nordisk Foundation

New research program receives DKK 100 million in funding from Novo Nordisk Foundation

Cancer drug may inhibit growth of cysts in patients with inherited form of kidney disease

Cancer drug may inhibit growth of cysts in patients with inherited form of kidney disease

Bacterial infections may trigger dysregulation of blood formation

Bacterial infections may trigger dysregulation of blood formation